Cargando…
A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs
[Image: see text] The use of small molecules to induce targeted protein degradation is increasingly growing in the drug discovery landscape, and protein degraders have progressed rapidly through the pipelines. Despite the advances made so far, their synthesis still represents a significant burden an...
Autores principales: | Bhela, Irene Preet, Ranza, Alice, Balestrero, Federica Carolina, Serafini, Marta, Aprile, Silvio, Di Martino, Rita Maria Concetta, Condorelli, Fabrizio, Pirali, Tracey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706574/ https://www.ncbi.nlm.nih.gov/pubmed/36323630 http://dx.doi.org/10.1021/acs.jmedchem.2c01218 |
Ejemplares similares
-
The [1,2,4]Triazolo[4,3‐a]pyridine as a New Player in the Field of IDO1 Catalytic Holo‐Inhibitors
por: Fallarini, Silvia, et al.
Publicado: (2021) -
1,2,4-Oxadiazole-Bearing Pyrazoles as Metabolically
Stable Modulators of Store-Operated Calcium Entry
por: Aprile, Silvio, et al.
Publicado: (2021) -
An Unexpected
Deuterium-Induced Metabolic Switch in
Doxophylline
por: Aprile, Silvio, et al.
Publicado: (2022) -
Antibody–PROTAC Conjugates Enable HER2-Dependent
Targeted Protein Degradation of BRD4
por: Maneiro, María, et al.
Publicado: (2020) -
The therapeutic effect of the BRD4-degrading PROTAC A1874 in human colon cancer cells
por: Qin, An-cheng, et al.
Publicado: (2020)